The Florida Senate
BILL ANALYSIS AND FISCAL IMPACT STATEMENT
(This document is based on the provisions contained in the legislation as of the latest date listed below.)
Prepared By: The Professional Staff of the Committee on Rules
BILL: CS/CS/SB 66
INTRODUCER: Rules Committee; Governmental Oversight and Accountability Committee; and Senator
Brodeur and others
SUBJECT: Revive Awareness Day
DATE: January 25, 2024 REVISED:
ANALYST STAFF DIRECTOR REFERENCE ACTION
1. Looke Brown HP Favorable
2. Limones-Borja McVaney GO Fav/CS
3. Looke Twogood RC Fav/CS
Please see Section IX. for Additional Information:
COMMITTEE SUBSTITUTE - Substantial Changes
I. Summary:
CS/CS/SB 66 creates “Victoria’s Law” and designates June 6 of each year as “Revive Awareness
Day.” The bill allows the Governor to issue an annual proclamation for the designation of
June 6th as “Revive Awareness Day.” The bill encourages the Department of Health (DOH) to
hold events to raise awareness of the dangers of opioid overdose and the availability and safe use
of opioid antagonists.
The bill is not expected to impact state or local government revenues and expenditures.
The bill takes effect upon becoming a law.
II. Present Situation:
According to the U.S. Centers for Disease Control and Prevention (CDC), in 2021 nearly 17,000
people in the United States died from overdosing on prescription opioids and nearly 71,000
people died from synthetic opioid overdoses.1 In Florida, from January to June of 2022, nearly
1
Centers for Disease Control and Prevention, Opioid Overdose, (Aug. 23, 2023),
https://www.cdc.gov/drugoverdose/deaths/opioid-overdose.html (last visited Jan. 25, 2024).
BILL: CS/CS/SB 66 Page 2
4,000 people died from opioid overdoses, while fentanyl, a synthetic opioid, caused another
2,744 deaths.2
Naloxone
Naloxone is a life-saving medicine that quickly reverses the effects of an opioid overdose. As an
opioid antagonist, it works by attaching to opioid receptors to reverse and block the effect of
opioids. In the case of an opioid overdose, an antagonist is capable of restoring normal breathing
in someone whose breathing has slowed dramatically or even stopped because of the overdose.3
Naloxone comes in two FDA-approved forms: injectable and prepackaged nasal spray. Injectable
brands of naloxone are offered by different companies listed in the FDA Orange Book under
“naloxone.” Prepackaged nasal sprays include generic naloxone, Narcan, and Kloxxado.4
Naloxone is a proven medicine that is an essential tool in hospital emergency rooms and
ambulance emergency kits. It reverses both heroin and opioid overdoses within minutes of its
administration and can save a life if given in time.5 Research shows that when naloxone and
overdose education are available to community members, overdose deaths decrease in those
communities.6
On March 29, 2023, the U.S. Food and Drug Administration approved Narcan, a four-milligram
naloxone hydrochloride nasal spray, for over-the-counter, nonprescription use, ensuring that the
life-saving medication is widely available without the requirement of obtaining a prescription.7
Victoria’s Voice Foundation
Victoria's Voice Foundation was established in 2019 by Jackie and David Siegel after losing
their 18-year-old daughter, Victoria, to an accidental drug overdose. Victoria's Voice is dedicated
to providing drug prevention education and naloxone awareness, support, and resources to those
affected by substance use.8
2
Florida Department of Law Enforcement, Drugs Identified in Deceased Persons by Florida Medical Examiners 2022
Interim Report, 3 (July 2023), available at https://www.fdle.state.fl.us/MEC/Publications-and-Forms/Documents/Drugs-in-
Deceased-Persons/2022-Interim-Drug-Report-FINAL.aspx (last visited Jan. 25, 2024).
3
National Institute on Drug Abuse, Naloxone Drug Facts (Jan. 2022), https://nida.nih.gov/publications/drugfacts/naloxone
(last visited Jan. 25, 2024).
4
Id.
5
John Strang et al., Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health
Application of an Emergency Medicine, 79(13) Drugs 1395-1418 (2019), available at
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728289/ (last visited Jan. 25, 2024)
6
Id.
7
The Food and Drug Administration, FDA Approves First Over-the-Counter Naloxone Nasal Spray (March 29, 2023),
https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray (last visited
Jan. 25, 2024).
8
Victoria’s Voice Foundation ,Victoria's Voice Foundation Launches First Ever National Naloxone Awareness Day on June
6 with Support from a Bipartisan Congressional Resolution, (Jun. 6, 2023), https://www.prnewswire.com/news-
releases/victorias-voice-foundation-launches-first-ever-national-naloxone-awareness-day-on-june-6-with-support-from-a-
bipartisan-congressional-resolution-301843527.html (last visited Jan. 25, 2024).
BILL: CS/CS/SB 66 Page 3
The U.S. Senate passed a joint resolution on June 6, 2023, recognizing June 6, 2023, as
Naloxone Awareness Day.9 The resolution promotes awareness of the life-saving drug,
Naloxone, which reverses opioid overdoses and prevents deaths. It also aims to educate members
of the public about the importance of recognizing the signs of overdose and equipping
themselves with the life-saving antidote.10
III. Effect of Proposed Changes:
The bill contains 15 whereas clauses that detail the negative effects of the opioid epidemic in the
United States.
Section 1 provides that this act may be cited as “Victoria’s Law.”
Section 2 creates s. 683.3342, F.S., to designate June 6 of each year as “Revive Awareness
Day.” The section authorizes the Governor to issue an annual proclamation designating June 6 as
“Revive Awareness Day.” The section also encourages the DOH to hold events to raise
awareness of the dangers of opioid overdose and the available and safe use of opioid antagonists
as an effective way to rapidly reverse the effects of opioid overdose.
Section 3 provides that the bill take effect upon becoming a law.
IV. Constitutional Issues:
A. Municipality/County Mandates Restrictions:
Not applicable. The mandate restrictions do not apply because the bill does not require
counties and municipalities to spend funds, reduce counties’ or municipalities’ ability to
raise revenue, or reduce the percentage of state tax shared with counties and
municipalities.
B. Public Records/Open Meetings Issues:
None.
C. Trust Funds Restrictions:
None.
D. State Tax or Fee Increases:
None.
9
S. Res. 250, 118th Cong. (2023).
10
Ed Markey, Markey, Scott Lead Bipartisan, Bicameral Resolution Designating June 6th Naloxone Awareness Day (June 6,
2023), https://www.markey.senate.gov/news/press-releases/markey-scott-scott-lead-bipartisan-bicameral-resolution-
designating-june-6th-naloxone-awareness-day (last visited Jan. 25, 2024).
 BILL: CS/CS/SB 66 Page 4
E. Other Constitutional Issues:
None identified.
V. Fiscal Impact Statement:
A. Tax/Fee Issues:
None.
B. Private Sector Impact:
None.
C. Government Sector Impact:
The bill is not expected to impact state or local government revenues and expenditures.
VI. Technical Deficiencies:
None.
VII. Related Issues:
None.
VIII. Statutes Affected:
This bill creates section 683.3342 of the Florida Statutes.
IX. Additional Information:
A. Committee Substitute – Statement of Substantial Changes:
(Summarizing differences between the Committee Substitute and the prior version of the bill.)
CS/CS by Rules on January 24, 2024:
The committee substitute encourages the DOH to hold events and raise awareness of all
opioid antagonists, instead of specifying Naloxone.”
CS by Governmental Oversight and Accountability on January 9, 2024:
The committee substitute designates June 6th of each year as “Revive Awareness Day”
instead of “Naloxone Awareness Day.
B. Amendments:
None.
This Senate Bill Analysis does not reflect the intent or official position of the bill’s introducer or the Florida Senate.